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ABSTRACT 
Globally, 500 million people are obese (body mass index [BMI] ≥30). In Sweden, 14% of the population is 
obese. Obesity is associated with an increased risk of mortality, cancer and several co morbidities. Bariatric 
surgery is the only treatment with documented long-term benefits, i.e. decreased mortality and co morbidities 
and sustainable weight loss. 
 
The aim of the thesis was to clarify effects of clinically relevant aspects of bariatric surgery and make 
comparisons with the general population of corresponding age, sex and calendar period. The included 
studies are nationwide Swedish population based retrospective cohort studies, comparing defined outcomes 
before and after bariatric surgery.  
 
Study I tested the hypothesis that the risk of obesity-related cancer decreases with increasing time after 
bariatric surgery. It included 13,123 patients who had undergone bariatric surgery in 1980-2006 in Sweden. 
Standardised incidence ratios (SIR) were calculated to assess risk. There was no overall decreased risk of 
cancer with increasing time after bariatric surgery (p for trend 0.4). Rather, the risk of colorectal cancer was 
increased with time after bariatric surgery (p=0.01).  
 
In study II, the risk of in-hospital care for obesity related diseases before and after bariatric surgery in 13,273 
patients during 1980-2006 was compared to a matched random sample of 132,730 individuals from the 
general population. Preoperative incidence rate ratios (IRR) and postoperative hazard ratios (HR) were 
calculated. The postoperative risk of diabetes, myocardial infarction, hypertension, stroke and angina 
remained increased compared to the general population. The risk estimates for diabetes (HR 1.2, 95% CI 
0.9-1.7) and myocardial infarction (HR 0.8, 0.4-1.5) were lower after gastric bypass than after restrictive 
bariatric procedures (HR 2.8, 96% CI 2.5-3.1 and HR 1.6, 95% CI 1.4-1.9, respectively). 
 
Study III assessed whether cholecystectomy is indicated as part of the bariatric surgery due to the known 
increased preoperative risk of gallstone formation. The need for cholecystectomy in a bariatric surgery cohort 
(n=13,443) during 1987-2008 was compared to the general population, and to two cohorts of patients who 
had undergone antireflux surgery (n=16,176) or appendectomy (n=154,751). An increased need for 
cholecystectomy after bariatric surgery was confirmed (SIR 5.5, 95% CI 5.1-5.8), but the absolute rate of 
cholecystectomy was low (8.5%) and the increased SIR after antireflux surgery (SIR 2.4, 95% CI 2.2-2.6) and 
appendectomy (SIR 1.7, 95% CI 1.6-1.7) indicated detection bias.  
 
Study IV addressed the risk of hospital admission for psychiatric disorders, including substance- and alcohol 
abuse before (IRR) and after (HR) bariatric surgery was compared to such admissions of the general 
population. The bariatric surgery cohort (n=12,277) during 1980-2006 was compared to a matched sample 
from the general population (n=122,770). Patients undergoing bariatric surgery were more likely to be 
hospitalised for all studied diagnoses prior to surgery compared to the general population, e.g. IRR of 
depression was 2.8 (95% CI 2.5-3.0). After gastric bypass, there was an increased risk of inpatient care for 
alcohol abuse compared to those undergoing a restrictive surgical procedure (HR 2.3, 95% CI 1.7-3.2). 
To conclude, bariatric surgery might not entail any reduced risk of obesity-related cancer with increasing time 
after surgery. The need for cholecystectomy following bariatric surgery was increased, but prophylactic 
cholecystectomy might not be generally recommended. Gastric bypass surgery seems to reduce the risk of 
inpatient care for diabetes and myocardial infarction, but increase the risk of inpatient care for alcohol abuse 
as compared to restrictive bariatric procedures. 
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